Insurance Coverage Expanded for Oklahomans with Epilepsy
Oklahoma lawmakers passed legislation to strengthen access to care and insurance protections for over 40,000 Oklahomans living with Epilepsy. Learn more.
Colorado Lawmakers Strengthen Epilepsy Awareness
Marking Purple Day, Colorado lawmakers work to improve education and documentation around epilepsy-related mortality. Learn more.
Addressing Sex-Specific Risks and Lifelong Care in Women with Epilepsy
From hormonal influences to reproductive health, women with epilepsy require specialized care that evolves with each stage of life. Learn More.
Suicidality May Predict Treatment Resistance in Newly Diagnosed Focal Epilepsy
Suicidality at the time of a focal epilepsy diagnosis was associated with a higher risk for future treatment resistance to antiseizure medications (ASMs). Learn More.
South Florida Teen Turns Adversity into Action for Others
Sofi Quintana doesn’t let her epilepsy diagnosis define her—she turned it into a movement so other teens never feel alone. Read the article.
Nationwide Seizure Safety Campaign Runs in AMC Theatres
A national seizure safety public service announcement (PSA) campaign will run in AMC Theatres across the United States. Learn more.
New Research Provides Evidenced-Based Dosing Strategies for Managing Epilepsy in Pregnancy
Clinicians now have clear guidance on how to adjust antiseizure medication, across gestation into the postpartum period, to reduce seizure risks to mother and child. Learn more
‘My Son Can Now Enjoy Life’: Children with Severe Form of Epilepsy Helped by New Drug
A new drug is transforming the lives of children born with a severe form of epilepsy. Eight-year-old Freddie Truelove is one of the first children in the UK to receive…
New Drug Cuts Seizures 91% in Children with Rare Form of Epilepsy
A new experimental drug is showing remarkable promise for children with Dravet syndrome. Learn more.
Changes in Anxiety Following Epilepsy Surgery
Researchers at Cleveland Clinic in Florida suggest that surgical treatment may reduce anxiety in about 25% of patients with temporal lobe epilepsy (TLE). Learn more.